Dr. Bob Gabbay - The Future of GLP-1s

In this conversation, Dr. Bob Gabbay discusses the evolution and impact of GLP-1 medications on weight loss and fitness. He highlights the importance of integrating lifestyle changes with medication, the current state of GLP-1 treatments, and the role of fitness professionals in supporting patients. The discussion also touches on the future of healthcare, technological innovations, and the potential of exercise mimetics. Takeaways GLP-1 medications have been around for 20 years but have recently exploded in popularity. The evolution of GLP-1 treatments has led to significant weight loss results, with newer medications achieving up to 22% weight loss. Lifestyle changes remain crucial for individuals using GLP-1 medications, complementing their effects. Statistics show that one in eight Americans have tried GLP-1 medications, but many stop within a year due to side effects or expectations. Common side effects of GLP-1 medications include nausea and gastrointestinal issues, with muscle wasting being a significant concern. Fitness professionals have a vital role in educating and supporting patients using GLP-1 medications. Technological innovations, such as AI and digital health tools, are transforming healthcare and patient engagement. The future of healthcare may see a greater integration of fitness professionals into the healthcare ecosystem. Exercise mimetics are being explored as a way to stimulate muscle growth without traditional exercise. By 2030, there is hope for improved access to GLP-1 medications and a shift in societal attitudes towards treating obesity as a disease. LINKS: https://goteamup.com/ https://podcastcollective.io/ https://egym.com/int